# FDA Inspection 1106283 - Optimus Pharma Private Limited - September 06, 2019

Source: https://www.keypedia.com/records/fda_inspections/optimus-pharma-private-limited/1a1a64ce-6cdc-44c7-8d36-28ba8d6d88cb
Source feed: FDA_Inspections

> FDA Inspection 1106283 for Optimus Pharma Private Limited on September 06, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106283
- Company Name: Optimus Pharma Private Limited
- Inspection Date: 2019-09-06
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1294786 - 2025-12-11](https://www.keypedia.com/records/fda_inspections/optimus-pharma-private-limited/e2f1197e-5534-4f9f-9e5f-bf97522d4ce6)
- [FDA Inspection 1208725 - 2023-06-23](https://www.keypedia.com/records/fda_inspections/optimus-pharma-private-limited/66f0a7c9-2544-4107-a868-3815644a5f7e)

Company: https://www.keypedia.com/companies/optimus-pharma-private-limited/d40f7c3d-bfe2-4d92-ae82-3bd26d23f240

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c